Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I)

Catastrophic APS, APS nephropathy and heart valve lesions

R. Cervera, M. G. Tektonidou, G. Espinosa, A. R. Cabral, Emilio Gonzalez, D. Erkan, S. Vadya, H. E. Adrogué, M. Solomon, G. Zandman-Goddard, Y. Shoenfeld

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis.

Original languageEnglish (US)
Pages (from-to)165-173
Number of pages9
JournalLupus
Volume20
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Antiphospholipid Syndrome
Heart Valves
Advisory Committees
Antiphospholipid Antibodies
Guidelines

Keywords

  • antiphospholipid antibodies
  • Catastrophic antiphospholipid syndrome
  • heart valve lesions
  • nephropathy

ASJC Scopus subject areas

  • Rheumatology

Cite this

Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I) : Catastrophic APS, APS nephropathy and heart valve lesions. / Cervera, R.; Tektonidou, M. G.; Espinosa, G.; Cabral, A. R.; Gonzalez, Emilio; Erkan, D.; Vadya, S.; Adrogué, H. E.; Solomon, M.; Zandman-Goddard, G.; Shoenfeld, Y.

In: Lupus, Vol. 20, No. 2, 02.2011, p. 165-173.

Research output: Contribution to journalArticle

Cervera, R, Tektonidou, MG, Espinosa, G, Cabral, AR, Gonzalez, E, Erkan, D, Vadya, S, Adrogué, HE, Solomon, M, Zandman-Goddard, G & Shoenfeld, Y 2011, 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions', Lupus, vol. 20, no. 2, pp. 165-173. https://doi.org/10.1177/0961203310395051
Cervera, R. ; Tektonidou, M. G. ; Espinosa, G. ; Cabral, A. R. ; Gonzalez, Emilio ; Erkan, D. ; Vadya, S. ; Adrogué, H. E. ; Solomon, M. ; Zandman-Goddard, G. ; Shoenfeld, Y. / Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I) : Catastrophic APS, APS nephropathy and heart valve lesions. In: Lupus. 2011 ; Vol. 20, No. 2. pp. 165-173.
@article{3de25ffc58624bd399ac2c9a2519f072,
title = "Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): Catastrophic APS, APS nephropathy and heart valve lesions",
abstract = "The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis.",
keywords = "antiphospholipid antibodies, Catastrophic antiphospholipid syndrome, heart valve lesions, nephropathy",
author = "R. Cervera and Tektonidou, {M. G.} and G. Espinosa and Cabral, {A. R.} and Emilio Gonzalez and D. Erkan and S. Vadya and Adrogu{\'e}, {H. E.} and M. Solomon and G. Zandman-Goddard and Y. Shoenfeld",
year = "2011",
month = "2",
doi = "10.1177/0961203310395051",
language = "English (US)",
volume = "20",
pages = "165--173",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I)

T2 - Catastrophic APS, APS nephropathy and heart valve lesions

AU - Cervera, R.

AU - Tektonidou, M. G.

AU - Espinosa, G.

AU - Cabral, A. R.

AU - Gonzalez, Emilio

AU - Erkan, D.

AU - Vadya, S.

AU - Adrogué, H. E.

AU - Solomon, M.

AU - Zandman-Goddard, G.

AU - Shoenfeld, Y.

PY - 2011/2

Y1 - 2011/2

N2 - The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis.

AB - The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis.

KW - antiphospholipid antibodies

KW - Catastrophic antiphospholipid syndrome

KW - heart valve lesions

KW - nephropathy

UR - http://www.scopus.com/inward/record.url?scp=79953321819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953321819&partnerID=8YFLogxK

U2 - 10.1177/0961203310395051

DO - 10.1177/0961203310395051

M3 - Article

VL - 20

SP - 165

EP - 173

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 2

ER -